IgE inhibition as a therapy for allergic disease

International Archives of Allergy and Immunology

Volumn 118, Issue 2-4, 1999, Pages 112-115

  Jardieu, Paula M ^a   Fick Jr , Robert B ^a  

^a GENENTECH INC   (United States)

Author keywords

Allergic rhinitis; Asthma; IgE; Monoclonal antibody

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; MONOCLONAL ANTIBODY; OMALIZUMAB; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ANTIGENICITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERANCE; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

EID: 0032965339     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024043     Document Type: Conference Paper

References (12)

1. Ishizaka K, Ishizaka T: Biological function of IgE antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol 1970;6: 25-31.
2. Nissim A, Eshhar Z: The human mast cell receptor binding site maps to the third constant domain of immunoglobulin E. Mol Immunol 1992;29:1065-1072.
3. Presta L, Gorman C, Shields R. McCray G, Holmes R, Jardieu P: The binding on human site of interaction between human immunoglobulin E and its high affinity receptor. J Biol Chem 1994;269:26368-28373.
4. Shields RL, Whether WR, Zioncheck K, O'Connell L, Fendly B, Presta LG, Thomas D, Saban R, Jardieu P: Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 1995; 107:308-312.
5. Saban R, Haak-Frendscho M, Zine M, Ridgway J, Gorman C, Presta L, Bjorling D, Saban M, Jardieu P: Human FcεRI-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitization of human and rhesus monkey lung. J Allergy Clin Immunol 1994;94:836-843.
6. Froelich J, Schoenhoff M, Dixon R, Trembley T, Ruppel J, Jardieu P: Single dose escalation study with an anti-IgE recombinant humanized monoclonal antibody (rhuMAb-E25) in atopic and non-atopic subjects. Clin Res submitted.
7. Malveaux FJ, Conroy MC, Adkinson NFJ, Lichtenstein LM: IgE receptors on human basophils: Relationship to serum IgE concentration. J Clin Invest 1978;62:176.
8. MacGlashan D Jr, Bochner B, Adelman D. Jardieu P, Togias A, McKenzie-White J, Sterbinsky S, Hamilton R, Lichtenstein L: Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-1445.
9. Casale TB, Bernstein IL, Busse WW, LaForce CR, Tinkelman DG, Stoltz RR, Dockhorr RJ, Reimann J, Su JQ, Pick RB, Adelman DC: Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-121.
10. Zweiman B: The late phase response: Role of IgE, its receptor, and cytokines. Curr Opin Immunol 1993;5:950-955.
11. Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Pick RB Jr, Boushey HA: The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828-1834.
12. Boulet LP, Chapman KR, Côté J, Kalra S, Bhagat R, Swystun VA, Laviolette M, Cleland LD, Deschesnes F, Su JQ, De Vault A, Pick RB Jr, Cockcroft DW: Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997;155: 1835-1840.